ReviewJugan geon-gang gwa jilbyeong2023
[Lessons from Korean Childhood Asthma Study Cohort and Needs for Long-term Prospective Study].
Review in Jugan geon-gang gwa jilbyeong, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Childhood asthma and the microbiome: from gut-lung axis mechanisms to precision prevention strategies.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asthma has heterogeneous groups with various pathophysiological mechanisms, and the course and the prognosis of the disease may vary depending on the specific phenotype or endotype. However, to date, no study has comprehensively investigated the clinical characteristics and natural history of childhood asthma according to phenotype or endotype. To address this gap in knowledge, we established the Korean childhood asthma study (KAS), a nationwide pediatric asthma cohort consisting of 1,009 children with asthma recruited from 19 hospitals from 2016 to 2018. Cluster analysis of the KAS cohort identified four distinct clusters: (1) male-dominant atopic asthma, (2) early onset atopic asthma with atopic dermatitis, (3) puberty onset, female-dominant atopic asthma, and (4) early onset, less atopic asthma. Recently, we have attempted to overcome the problem of missing data during tracking periods by linking KAS cohort clinical data and Health Insurance Review and Assessment Service (HIRA) data. We also found 4 clusters based on the frequency of asthma exacerbations in children aged 0-12 and the degree of asthma medication use in children aged 6-12, suggesting that frequent exacerbations during early childhood can affect airway growth during childhood. To establish evidence-based national policies for whole life asthma prevention and management, a long-term prospective follow-up study focusing on the remission of childhood asthma and its transition to adulthood is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.